International Flavors & Fragrances Inc (IFF) Q1 2019 Earnings Call Transcript
IFF earnings call for the period ending March 31, 2019.
International Flavors & Fragrances
IFF
IFF
$144.81
$0.07
0.0%
BATS BZX Real Time Price as of July 16, 2019, 4:00 p.m. EDT
View Interactive IFF Charts
The Company is a creator and manufacturer of flavor and fragrance compounds used to impart or improve the flavor or fragrance in a variety of consumer products.
News & Analysis: International Flavors & Fragrances
The Fool has written over 100 articles on International Flavors & Fragrances.
International Flavors & Fragrances Inc (IFF) Q4 2018 Earnings Conference Call Transcript
IFF earnings call for the period ending December 31, 2018.
International Flavors & Fragrances Inc (IFF) Q3 2018 Earnings Conference Call Transcript
IFF earnings call for the period ending September 30, 2018.
3 Companies That Don't Seem Like Synthetic Biology Stocks, but Actually Are
The field of synthetic biology has not been good to investors. But maybe we've just been looking in the wrong places.
Why International Flavors & Fragrances, Tower Semiconductor, and Dentsply Sirona Slumped Today
Find out which of these companies made an acquisition play.
Here's Why Shares of International Flavors & Fragrances Collapsed Today
The sweet taste of strong first-quarter 2018 earnings couldn't overcome the stench of a proposed merger.
3 Dividend Stocks I'd Buy Right Now
They may not be the most popular dividend stocks, but A. O. Smith, Enable Midstream Partners LP, and International Flavors & Fragrances have a lot to offer your portfolio.
How to Make Money From Engineered Biology
Direct investment in industrial synthetic biology stocks hasn't worked out for investors. It's time for a different approach in the current environment.
Why International Flavors & Fragrances Inc. Plunged 14% Today
Earnings are in decline and that didn't please investors today.
Biotech in Your Vanilla Ice Cream? Here's the Scoop.
Put emotions aside and consider the facts before you roll your eyes at biotech's advance on the vanilla-flavoring market. As it turns out, you'll probably welcome the latest breakthrough with open arms.
